ASH Clinical News May 2015 | Page 94

BACK of the BOOK Heard in the Blogosphere American Medical Association @AmerMedicalAssn How does your workweek compare to your peers? No Simple Solutions “To imagine that we will find a simple solution, I think, doesn’t do service to the true complexity of the problem. Cancer is part of our genetic inheritance. We will always have cancer amidst us, within us, amongst us.” —Siddhartha Mukherjee, MD, PhD, in the PBS documentary series, Cancer: The Emperor of All Maladies Embryo Editing: Lessons from Failure Scientists weigh in on Chinese researchers’ attempt to edit genes in human embryos with a technique (CRISPR) that would permanently alter the DNA of every cell so that any changes would be passed on from generation to generation. The experiment failed but raised important scientific and ethical questions. “Their study should give pause to any practitioner who thinks the technology is ready for testing to eradicate disease genes during in vitro fertilization. This is an unsafe procedure and should not be practiced at this time, and perhaps never.” —George Q. Daley, MD, PhD, director of the Stem Cell Transplantation Program at Boston Children’s Hospital and Dana-Farber Cancer Institute, in The New York Times 92 ASH Clinical News “The number-one concern with this type of technology is that it changes the germline; as long as those lineages exist, they will be propagated to children, and to children’s children, and so on. The fact that only the wealthy initially may have access to this technology is another ethical issue. Suppose that everybody could have access to this? Is this still a bad idea?” —Eric Schadt, PhD, director of the Icahn Institute for Genomics and Multiscale Biology at Mount Sinai Hospital, on CBS This Morning “Although it has attracted a lot of attention, the study simply underscores the point that the technology is not ready for clinical application in the human germline. Application of the technology needs to be on hold pending a broader societal discussion of the scientific and ethical issues surrounding such use.” —Jennifer A. Doudna, PhD, a professor of Molecular and Cell Biology and Chemistry at University of California: Berkeley, and a pioneer of the CRISPR technique, in National Geographic’s “Phenomena” blog What Good is “Raising Awareness”? “People might conflate being knowledgeable about a health issue with taking action to address it. These awareness [days] seem to be reinforcing that if you’re aware of the health issue, it’s a good step, and it might be even sufficient to address the health issue. That really flies in the face of the complexity of the various forces that influence a person’s health and a population’s health.” —Jonathan Purtle, DrPH, MPH, MSc, assistant professor at Drexel University’s School of Public Health, discussing his recent study of whether “awareness days” improved health in The Atlantic May 2015